Navigation Links
Racial differences in willingness to exhaust personal finances for life-sustaining care
Date:4/25/2011

Minority racesespecially Blacksare more willing than Whites to expend personal financial resources to prolong life after being diagnosed with lung or colorectal cancer, even if it means using up all of their personal financial resources. That is the conclusion of a new study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. Delivering quality cancer care that is in accordance with patients' wishes requires a better understanding of the reasons for these differences in preference.

Minority patients receive more aggressive care at the end of life, but it is unclear whether this trend is consistent with their preferences. Also, researchers know little about patients' willingness to spend personal financial resources to receive life-prolonging care, and even less about this willingness in patients from different racial and ethnic groups. To investigate, Michelle Martin, PhD, of the University of Alabama at Birmingham, and her colleagues compared the willingness to use personal financial resources to extend life among White, Black, Hispanic, and Asian cancer patients. The study included 4,214 participants in the Cancer Care Outcomes Research and Surveillance (CanCORS) study, a population- and health care system-based, multi-center, observational study of patients with newly diagnosed lung or colorectal cancer. Patients were interviewed about myriad aspects of their care including their willingness to trade their personal financial resources for life-prolonging cancer treatment rather than receive treatment that costs them less but would not allow them to live as long.

The researchers found that 80 percent of Blacks reported a willingness to spend all resources to extend life, versus 54 percent of Whites, 69 percent of Hispanics, and 72 percent of Asians. After accounting for a host of factors including income, disease stage, quality of life, patients' age, patients' perceived time left to live, and other medical illnesses, Blacks were 2.41 times more likely to opt for expending all personal financial resources to extend life than Whites. The preferences of Hispanic and Asian patients were intermediate between White and Black patients. Determining the reasons for these differences in preference requires further study.

Several other factors were associated with a willingness to expend resources to prolong life: younger age, a lower number of individuals that they financially supported, divorced/separated marital status, a belief that life expectancy is in God's hands, and a higher level of social support.

"This is the first national study of lung and colorectal cancer survivors to examine the willingness to exhaust personal finances for life sustaining care. Our results highlight the complexity of treatment decisions and the factors that influence patient preferences," said Dr. Martin. According to the authors, continued research on this topic may facilitate the delivery of coordinated cancer care that consistently reflects patient values and preferences.


'/>"/>

Contact: Jennifer Beal
healthnews@wiley.com
44-124-377-0633
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Racial Disparities Remain for Health Care for Vets
2. New perspective diminishes racial bias in pain treatment
3. Potassium levels possible key to racial disparity in Type 2 diabetes
4. Racial and ethnic minority adolescents less likely to receive treatment for major depression
5. Study Finds Racial Disparity in Breast Cancer Outcomes
6. Racial and ethnic disparities impact care for children with frequent ear infections
7. Chicago racial disparities in breast cancer mortality significantly higher than national average
8. Notable racial disparities in diagnosis, treatment and outcomes of colorectal cancer
9. Insurance and socioeconomic status do not explain racial disparities in breast cancer care
10. Are we ready for medical treatment based on a patients racial and ethnic background?
11. Why A Multi-Racial, Multi-Ethnic Society Needs Open and Sustained Dialogue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: